IPO registrations (S-1, F-1) · Registrants
INSPIRE PHARMACEUTICALS INC
- SEC CIK
- 1040416 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-02-25, last 2000-08-02; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 2000-08-03
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 4222 EMPEROR BLVD STE 200, Durham, NC 27703-8466
- EIN
- 04-3209022
- EDGAR entity type
- operating
- Insiders and CEO pay
- INSPIRE PHARMACEUTICALS INC on the corporate pages
Offering terms
- Proposed price range
- $10.00–$12.00 per share (S-1/A filed 2000-08-02)
- Final price
- $12.00 per share, within the range (424B1 filed 2000-08-03, an initial public offering)
- Shares sold
- 5,500,000
- Gross proceeds
- $66,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ISPH
- Lead underwriters
- Deutsche Bank (1,935,000 shares); Hambrecht & Quist
- Syndicate
- Piper Sandler (967,250); J.P. Morgan (1,397,750); BofA Securities (90,000); CIBC World Markets (90,000); Merrill Lynch (90,000); Morgan Stanley (90,000); Robertson Stephens (90,000); Citigroup (90,000); Adams Harkness (60,000); Dominick & Dominick LLC (60,000); Emerging Growth Equities, Ltd (60,000); Fahnestock & Co. Inc (60,000); C.L. King & Associates (60,000); Legg Mason (60,000); Edgar M. Norris & Co. Inc (60,000); Truist Securities (60,000); C.E. Unterberg, Towbin (60,000); Wachovia (60,000); Wedbush Securities (60,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INSPIRE PHARMACEUTICALS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: INSPIRE PHARMACEUTICALS INC EXACT (EIN (EXACT))
- Federal award recipient: INSPIRE PHARMACEUTICALS, INC. Fuzzy (name and state)
- SEC filer: INSPIRE PHARMACEUTICALS INC EXACT (CIK (EXACT))
- Person page: George B Abercrombie Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
- Person page: Jeffrey R Jay Md Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
- Person page: William R Ringo Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-02-25 | S-1 | S-1 (registration) | INSPIRE PHARMACEUTICALS INC | 0000950130-00-000892 ↗ |
| 2000-03-30 | S-1/A | S-1/A (amendment) | INSPIRE PHARMACEUTICALS INC | 0000950130-00-001722 ↗ |
| 2000-06-29 | S-1/A | S-1/A (amendment) | INSPIRE PHARMACEUTICALS INC | 0000950130-00-003680 ↗ |
| 2000-07-11 | S-1/A | S-1/A (amendment) | INSPIRE PHARMACEUTICALS INC | 0000950130-00-003829 ↗ |
| 2000-07-24 | S-1/A | S-1/A (amendment) | INSPIRE PHARMACEUTICALS INC | 0000950130-00-004020 ↗ |
| 2000-08-02 | S-1/A | S-1/A (amendment) | INSPIRE PHARMACEUTICALS INC | 0000950130-00-004167 ↗ |
| 2000-08-03 | 424B1 | 424B1 (final prospectus) | INSPIRE PHARMACEUTICALS INC | 0000950130-00-004193 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-08-02 | S-1/A | registration statement | $10.00–$12.00 | $11.00 | 5,500,000 | $60,500,000 | Nasdaq ISPH | 3 | primary document; range, price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
| 2000-08-03 | 424B1 | final prospectus | $12.00 | 5,500,000 | $66,000,000 | Nasdaq ISPH | 21 | primary document; price sentence, shares sentence, proceeds computed, underwriting table 20, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BENNETT MARY B | Officer | Exec. VP, Operations/Comm. | 6 | 2006–2007 | |
| Brazzell Romulus K | Officer | EVP & Head, Ophthalmology; EVP, Medical & Scientific; Sr. VP, Ophthalmic R & D | 21 | 2006–2011 | |
| EVANS RICHARD M | Officer | VP, Pharmaceutical Development | 1 | 2006 | |
| KELLERMAN DONALD J | Officer | Senior VP, Development | 10 | 2006–2008 | |
| Pea Barry G | Officer | Exec. VP, Corp. Dev. & GC | 1 | 2006 | |
| SCHACHLE JOSEPH K | Officer | EVP, Chief Commercial Ops; EVP & Chief Corp & Comm'l Ops; EVP, Pulmonary Business; Sr. VP, Marketing & Sales | 21 | 2006–2011 | |
| SHAFFER CHRISTY L | Director,Officer | President & CEO | 19 | 2006–2009 | |
| STAAB THOMAS R II | Officer | CFO & Treasurer; EVP, CFO & Treasurer | 22 | 2006–2011 | |
| YERXA BENJAMIN R | Officer | Chf Sci Off & EVP Strat Ops; Chief, Sci. Op. & Alliances; EVP & Chf, Research & Develop | 30 | 2006–2010 | |
| DEERFIELD CAPITAL LP | TenPercentOwner; TenPercentOwnerOther | 8 | 2006–2007 | ||
| DEERFIELD INTERNATIONAL LTD | TenPercentOwner; TenPercentOwnerOther | 6 | 2006–2007 | ||
| DEERFIELD MANAGEMENT CO /NY | TenPercentOwner; TenPercentOwnerOther | 8 | 2006–2007 | ||
| DEERFIELD PARTNERS, LP | TenPercentOwner; TenPercentOwnerOther | 6 | 2006–2007 | ||
| Deerfield Special Situations Fund International LTD | TenPercentOwner; TenPercentOwnerOther | 8 | 2006–2007 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwner; TenPercentOwnerOther | 8 | 2006–2007 | ||
| Flynn James E | TenPercentOwner | 8 | 2006–2007 | person page Fuzzy | |
| Spagnardi Joseph M | Officer | Senior VP, GC & Secretary | 22 | 2006–2011 | |
| FREY KIP | Director | 8 | 2006–2011 | ||
| HOLMER ALAN F | Director | 6 | 2006–2011 | ||
| Kent Richard S | Director | 6 | 2006–2011 | ||
| LEE KENNETH B JR | Director | 8 | 2006–2011 | ||
| RINGO WILLIAM R | Director | 2 | 2006–2007 | person page Fuzzy | |
| GREAT POINT PARTNERS LLC | TenPercentOwner | 4 | 2006–2007 | ||
| JAY JEFFREY R | TenPercentOwner | 4 | 2006–2007 | person page Fuzzy | |
| Hutson Nancy J | Director | 9 | 2006–2011 | ||
| LEFF JONATHAN S | Director | 7 | 2007–2011 | ||
| Warburg Pincus Private Equity IX, L.P. | TenPercentOwner | 4 | 2007–2011 | ||
| KAYE CHARLES R | TenPercentOwner | 3 | 2007–2011 | ||
| LANDY JOSEPH | TenPercentOwner | 3 | 2007–2011 | ||
| WARBURG PINCUS & CO | TenPercentOwner | 3 | 2007–2011 | ||
| Warburg Pincus IX LLC | TenPercentOwner | 3 | 2007–2011 | ||
| WARBURG PINCUS LLC | TenPercentOwner | 3 | 2007–2011 | ||
| Warburg Pincus Partners LLC | TenPercentOwner | 3 | 2007–2011 | ||
| ADAMS ADRIAN | Director,Officer | President and CEO | 5 | 2010–2011 | |
| ABERCROMBIE GEORGE B | Director | 5 | 2010–2011 | person page Fuzzy | |
| KOVEN ANDREW I | Officer | EVP & Chief Admin & Legal Ofc | 5 | 2010–2011 | |
| Johnson Charles A | Officer | EVP of R&D & Chief Med. Ofcr. | 4 | 2010–2011 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | INSPIRE PHARMACEUTICALS, INC. | NC | Federal spending (USAspending) | name and state |
| Patent assignee | Inspire Pharmaceuticals, Inc. | NC | Patents (USPTO) | name and state |
| SEC filer | INSPIRE PHARMACEUTICALS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Inspire Pharmaceuticals, Inc. | NC | Trademarks (USPTO) | name and state |
| Business registration | INSPIRE PHARMACEUTICALS, INC. | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | INSPIRE PHARMACEUTICALS INC | EIN (EXACT) | ||
| Person page | George B Abercrombie | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) | |
| Person page | Jeffrey R Jay Md | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) | |
| Person page | William R Ringo | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NC first:
- SALIX PHARMACEUTICALS LTD NC
- TRIANGLE PHARMACEUTICALS INC NC
- POZEN INC /NC NC
- ARGOS THERAPEUTICS INC NC
- CHIMERIX INC NC
- ENDEAVOR PHARMACEUTICALS INC NC
- CORNERSTONE THERAPEUTICS INC NC
- Talecris Biotherapeutics Holdings Corp. NC
- Biolex Therapeutics, Inc. NC
- CURAXIS PHARMACEUTICAL Corp NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health